MPG overexpression was previously associated with cellular sensitisation to alkylation: studies involving breast, glioma, and ovarian cancer cell lines reported that MPG overexpression conferred sensitivity to alkylating agents, such as TMZ [19, 38]. The gene discussed is MPG; the disease is central nervous system cancer.